UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________

FORM 8-K
______________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 13, 2016

______________
 
 
CoroWare, Inc.
(Exact name of registrant as specified in its charter)
______________
 

 
 
 
 
Delaware
000-33231
95-4868120
(State of Other Jurisdiction
 of Incorporation)
(Commission
 File Number)
(IRS Employer
 Identification Number)

601 108th Avenue Northeast, Suite 1900
Bellevue, WA 98004
 (Address of principal executive offices)

(800) 641-2676
(Registrant's telephone number, including area code)

______________
 
Copies to:

Gary L. Blum, Esq.
Law Offices of Gary L. Blum
3278 Wilshire Boulevard, Suite 603
Los Angeles, CA 90010
Phone: (213) 381-7450
Fax: (213) 384-1035

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
Item 7.01. Regulation FD Disclosure.

On June 13, 2016, CoroWare, Inc. (the “Company”) issued a press release announcing a shareholder update with a discussion on achieving operational profitability and attracting long term investment. The press release is included as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

This Item 7.01 and the press release attached hereto as Exhibit 99.1 are being furnished to the Securities Exchange Commission in satisfaction of the public disclosure requirements of Regulation FD and shall not be deemed “filed” for any purpose.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits.
 
 
   
 
 
 
Exhibit No.
 
Description
99.1
 
Press Release issued by CoroWare, Inc. on June 13, 2016



Signature
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
COROWARE, INC.
 
 
 
 
 
Date: June 13, 2016
By:
/s/ Lloyd Spencer
 
 
 
Lloyd Spencer
 
 
 
Chief Executive Officer